Chennai’s positivity rate has seen a significant reduction, standing 8.93% on Sunday.

Two doctors wearing face shields sit in a fever camp in Chennai as one man gets checked for symptoms of COVID-19 Image for representation/PTI
Coronavirus Coronavirus Monday, July 20, 2020 - 13:23

Chennai’s positivity rate stands at 8.93% after having tested 14,030 samples on Sunday, as per data released by the Greater Chennai Corporation (GCC). The city recorded 1,254 new cases of COVID-19 on Sunday. The city’s positivity rate has seen a significant reduction after touching a high of 31.67% on June 15.  

Chennai presently has 15,042 patients who are being treated for COVID-19. A total of 85,859 persons have tested positive in Chennai district as of Sunday.  

As per zone-wise breakup of infections in Chennai, Kodambakkam has 2,119 active cases - the highest in the city. Anna Nagar has 1,586 active cases, followed by Teynampet (1,316), Adyar (1,085), Royapuram (1,033) and Thiru Vi Ka Nagar (1,009). 

According to the Chennai Corporation, the growth rate of COVID-19 cases for the last seven days until July 19 stands at 0%, indicating a plateauing of COVID-19 cases. However, Thiru Vi Ka Nagar in north Chennai recorded the highest growth rate of new cases over the past week at 8.4%, followed by Perungudi at 6.9%.  Alandur reported a 5% growth rate of new cases, Manali 3.7%, Sholinganallur 1.9%, Adyar 1% and Anna Nagar 0.9%.

Significantly, eight out of the 15 zones across Chennai recorded a negative growth rate over the past week. Kodambakkam saw its growth rate down to -4%, Madhavaram to -3.4% and Royapuram to -3.2%.

Chennai reported 27 deaths as per Sunday’s bulletin, taking the city’s total fatalities due to COVID-19 to 1,434. That’s a case fatality rate of 1.67%. 

According to GCC, Teynampet, which falls under Central Chennai, has the highest number of deaths at 209, followed by Tondiarpet (192), Royapuram (176), Thiru Vi Ka Nagar (153) and Kodambakkam (152).

A total of 69,382 COVID-19 patients or 81% have recovered from the disease. 

 

Show us some love and support our journalism by becoming a TNM Member - Click here.